Browse By: Country ι Category ι Publisher ι Tag

Competitor Analysis: Cancer Vaccines

Pages » 179
Published By » La Merie Publishing
Price » $1112
In stock
View Report Details
Description

The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines to fight cancer as of March 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report. Projects are listed according to their main antigenic constituents: peptides, recombinant proteins, idiotype antibody, DNA (plasmid, expression vector), RNA, virus-like particles (VLP), dendritic cells, tumor cells (tu... Click here for more details


Oncology Pipeline Database: 6-Month Subscription
Oncology Pipeline Database: 6-Month Subscription Product description Subscription to La Merie’s proprietary Oncology Pipeline Database provides online access to more than 3,000 project entries in oncology. Each project is specified for its Target or Mechanism of Action, Product Category and
Published Date: Feb 2010
Price: $1544
Oncology Pipeline Database: 1-Year Subscription
Oncology Pipeline Database: 1-Year Subscription Product description Subscription to La Merie’s proprietary Oncology Pipeline Database provides online access to more than 3,000 project entries in oncology. Each project is specified for its Target or Mechanism of Action, Product Category and R
Published Date: May 2010
Price: $2316
Flat-Rate Subscription to La Merie Reports with 24/7 Online Access
Subscription to this product provides online access during one year to all reports published by La Merie and available in the online store during the subscription. Among La Merie reports are more than 100 Competitor Analysis reports as well as a growing number of Brief and Full Reports. La Merie r
Published Date: Jun 2010
Price: $5146
R&D Drug Pipeline Database: 1-Year Subscription
R&D Drug Pipeline Database: 1-Year Subscription Product description Subscription to La Meries proprietary R&D Drug Pipeline Database provides online access to more than 12,000 project entries in all therapeutic areas and product categories. Each project is specified for its Target or Mecha
Published Date: Aug 2010
Price: $7719
R&D Drug Pipeline Database: 2-Months Subscription
R&D Drug Pipeline Database: 2-Months Subscription Product description Subscription to La Meries proprietary R&D Drug Pipeline Database provides online access to more than 12,000 project entries in all therapeutic areas and product categories. Each project is specified for its Target or Mec
Published Date: Aug 2010
Price: $2573
Antibody Pipeline Database: 1-Year Subscription
Subscription to La Meries proprietary Antibody Pipeline Database provides online access to more than 1,600 project entries for therapeutic antibodies on the market and in research & development. Each project is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase.
Published Date: Nov 2010
Price: $1544
Therapeutic Protein Pipeline Database: 1-Year Subscription
Subscription to La Merie’s proprietary Therapeutic Protein Pipeline Database provides online access to more than 1,700 project entries for therapeutic proteins on the market and in research & development. Each project is specified for its Target or Mechanism of Action, Therapeutic Area a
Published Date: Feb 2011
Price: $1544
RNA Therapeutics Pipeline Database: 1-Year Subscription
RNA Therapeutics Pipeline Database: 1-Year Subscription Product description Subscription to La Merie’s proprietary RNA Therapeutics Pipeline Database provides online access to RNA Therapeutics on the market and in research & development. RNA Therapeutics include the classes of antisense,
Published Date: Mar 2011
Price: $772
Vaccine Pipeline Database: 1-Year Subscription
Vaccine Pipeline Database: 1-Year Subscription Product description Subscription to La Merie’s proprietary Vaccine Pipeline Database provides online access to more than 1,200 project entries for prophylactic and therapeutic vaccines on the market and in research & development. Eac
Published Date: Oct 2011
Price: $1287
Competitor Analysis: Targeted Therapy of Hepatitis C
The present Competitive Intelligence Report about Targeted Therapy of Hepatitis C provides a competitor evaluation in the field of specifically targeted antiviral therapeutics for hepatitis C (STAT-C) as of August 2011. Purchase of the downloadable pdf report includes a 6-month online access to
Published Date: Aug 2011
Price: $772

 


 

Related News

The Manufacturing Supply Chains to be Restructured by 3D Printing Technology
The trend of 3D printing has evolved within a very short period of time. Back in the 1980s when it was built by Charles Hull, it was used as a tool for creating basic polymer objects. However, today this technology is proving its worth in various manufacturing sectors right from developing complex aircrafts and parts of racing cars, to prostheses and human organs. The business world today is recognizing the potential of 3D printing which ensures environmentally sustainable, efficient, and cos
Date: Nov 26

Banks Need Two Decades to Tackle ‘Toxic Culture’, says Cass Business School’s Report
“UK banks will be seen facing two decades to clear up the ‘toxic culture’ that was decades in making and has cost more than US$60 billion in compensation and fines”, Cass Business School and Think Tank New City Agenda concluded in a joint study report. According to the joint study report, from 2010 to 2014, banks were forced to compensate consumers by making provisions of at least US$42.51 billion for insurance products that were not sold properly. It has cost lenders
Date: Nov 26

Dutch Biotech Prosena gets Milestone Payments; BioMarin acquires it for US$840 Million
BioMarin Pharmaceuticals Inc. has agreed to pay US$840 million, which includes milestone payments, in accordance to buy Prosena, a Dutch bio-pharmaceutical company. The share prices of Prosena holding NV (RNA) rose above the offer that is made by BioMarin, after the announcement of the deal. With this deal, BioMarin focuses on the expansion of its portfolio of drugs to treat rare diseases as the acquisition will provide rights to various orphan drug candidates, mainly Drisapersen that is bein
Date: Nov 25

2,500 Construction Workers to be Tested in UAE
A project initiative had recently been launched in the UAE that is designed to test the skills of almost 2,500 workers in the construction sector before they gain entry into the UAE, as announced by the UAE Ministry of Labor. The Minister of Labor, Saqr Ghobash, said the new project comes as an attempt by the Ministry of Labor towards obtaining cooperation and partnership with concerned government bodies and companies from the private sector to obtain future labor market goals. This project a
Date: Nov 24

U.S. auto regulator Orders Expansion of Takata Air Bags Recalls
U.S. auto safety regulators have ordered Japanese safety equipment manufacturer Takata Corp and five automakers to expand recalls of cars which had Takata airbags in them. The companies ordered to expand recalls include Honda, Chrysler, BMW, Mazda and Ford.  Already, nearly 16 million cars from around the globe have been recalled over the issue of faulty Takata airbags in the past 6 years. Of these, nearly 11 million are from the U.S. alone. The pressure of expanding regional recalls of
Date: Nov 20

Telecom Italia Expresses Interest in Buying Stake in Metroweb
Italian telecommunications company Telecom Italia has expressed its desire to buy a controlling stake in Metroweb – Italian fiber optic provider. Telecom Italia is looking to increase its investments in faster networks and is being met with stiff competition from rival Vodafone who is also reportedly courting Metroweb.  Metroweb is owned by F2i, an infrastructure fund. F2i spokesperson informed the media that Metroweb had been getting investors for quite some time but the company h
Date: Nov 20

Baker Hughes to be taken over by Halliburton
Baker Hughes, a rival company of Halliburton’s, providing oilfield services will soon be bought by the latter for a deal worth US$ 34.6 billion. Such a step denotes the immediate impact that falling prices have on the energy industry. Over the past five months, worldwide oil prices have declined by almost 31%. Fall in oil prices are forcing the oil services companies to resort to cost cutting by either scaling back drilling or delaying the same. Thus, this means lesser work for Baker Hughe
Date: Nov 19

Asia Follows China in Push for Clean Energy
The Chinese economy is beginning to cool, but its requirement for energy is still on the rise. So is its capacity to generate this extra energy from various sources, including wind, solar, hydroelectric, coal and nuclear. Other Asian countries are quickly following suit due to skyrocketing energy needs where industrialization is overtaking the production of power from renewable sources. Experts calculate that more than US$250 billion will be spent per year in Asia to create more sources of
Date: Nov 19

RF Executives Plan to Capture the Mobile Market Via Merger
The planned amalgamation between Oregon-based TriQuint Semiconductor Inc., and Greensboro-based RF Micro Devices Inc., will allow this merger to grow into several areas of the industry, including the mobile markets and defense, said both the companies’ executives on Tuesday.  Both the company officials summarized plans about their unique position to win in the investor day presentation. However, the combined name of the company will be Qorvo.  Both TriQuint and RF manufactu
Date: Nov 19

Mexican Supplier Cooperation for BMW, Mercedes
Daimler is currently working with its rival automaker BMW to create a supplier chain for new factories in Mexico. This was announced on Monday by Klaus Zehender, the divisional board member for supplier quality and procurement at Mercedes-Benz, Daimler. The effort comes as a part of a larger one by Mercedes-Benz to expand its chain of local suppliers to their factories in China, South Africa, United States, and Mexico. In the first half of this year, Daimler and BMW announced their plans t
Date: Nov 18

Upcoming Reports

Oncology Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
Oncology is the study of Cancer. Oncology devices market consists of medical devices involved in diagnosing and treating the disease cancer. The Oncology devices market could be segmented into 2 major categories: by type and by applications. There are two types of Brachytherapy devices and the E
Published By: Transparency Market Research
Price: $4595
Biologicals In Oncology Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Biological therapy is defined as use of living organisms and substances derived from organism or synthetically produced version of such substances in laboratories to treat the disease condition. Some of the biological therapies for cancer involve vaccines or bacteria to stimulate the body’s de
Published By: Transparency Market Research
Price: $4795